Experiment set11IT007 for Paraburkholderia graminis OAS925

Compare to:

Plant=Brachypodium_distachyon; PlantTreatment=None; Sample=rhizosphere; GrowthSubstrate=0.5X_MS_liquid; Collection=outgrowth_R2A_with_Tween_and_Cycloheximide; Time=21_days

Group: in planta
Media: + Plant=Brachypodium_distachyon; PlantTreatment=None; Sample=rhizosphere; GrowthSubstrate=0.5X_MS_liquid; Collection=outgrowth_R2A_with_Tween_and_Cycloheximide; Time=21_days
Culturing: Burkholderia_OAS925_ML2, pot, at 26 (C), (Solid)
By: Marta Torres on 26-Aug-21

Specific Phenotypes

For 13 genes in this experiment

For in planta Plant=Brachypodium_distachyon; PlantTreatment=None; Sample=rhizosphere; GrowthSubstrate=0.5X_MS_liquid; Collection=outgrowth_R2A_with_Tween_and_Cycloheximide; Time=21_days in Paraburkholderia graminis OAS925

For in planta Plant=Brachypodium_distachyon; PlantTreatment=None; Sample=rhizosphere; GrowthSubstrate=0.5X_MS_liquid; Collection=outgrowth_R2A_with_Tween_and_Cycloheximide; Time=21_days across organisms

SEED Subsystems

Subsystem #Specific
Polyamine Metabolism 4
Aromatic amino acid degradation 1
Bacterial Chemotaxis 1
Fructose utilization 1
NAD and NADP cofactor biosynthesis global 1
Peptidoglycan Biosynthesis 1
Ribitol, Xylitol, Arabitol, Mannitol and Sorbitol utilization 1
Type IV pilus 1
Xylose utilization 1

Metabolic Maps

Color code by fitness: see overview map or list of maps.

Maps containing gene(s) with specific phenotypes:

MetaCyc Pathways

Pathways that contain genes with specific phenotypes:

Pathway #Steps #Present #Specific
xylitol degradation I 2 2 1
D-xylose degradation I 2 2 1
D-arabinitol degradation I 2 2 1
L-tryptophan degradation I (via anthranilate) 3 3 1
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde 5 3 1
3-hydroxy-4-methyl-anthranilate biosynthesis II 5 3 1
3-hydroxy-4-methyl-anthranilate biosynthesis I 6 2 1
3-hydroxyquinaldate biosynthesis 8 2 1
peptidoglycan biosynthesis II (staphylococci) 17 12 2
peptidoglycan biosynthesis IV (Enterococcus faecium) 17 12 2
peptidoglycan biosynthesis V (β-lactam resistance) 17 11 2
NAD de novo biosynthesis II (from tryptophan) 9 7 1
quinoxaline-2-carboxylate biosynthesis 10 4 1
peptidoglycan biosynthesis I (meso-diaminopimelate containing) 12 12 1
peptidoglycan maturation (meso-diaminopimelate containing) 12 4 1
L-tryptophan degradation IX 12 4 1
L-tryptophan degradation XII (Geobacillus) 12 4 1
superpathway of NAD biosynthesis in eukaryotes 14 8 1
peptidoglycan biosynthesis III (mycobacteria) 15 11 1
L-tryptophan degradation III (eukaryotic) 15 6 1
superpathway of glucose and xylose degradation 17 16 1
L-tryptophan degradation XI (mammalian, via kynurenine) 23 7 1
superpathway of aromatic compound degradation via 3-oxoadipate 35 19 1
superpathway of pentose and pentitol degradation 42 21 1
superpathway of aromatic compound degradation via 2-hydroxypentadienoate 42 13 1